stockrow
Friday 6 November 2026
Export ITGR’s income statement to Excel — free account
Integer Holdings Corporation
ITGR Healthcare Medical Devices
Integer Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 7.98% from fiscal 2024.
- Revenue
- −3.86%
- EPS
- −61.0%
- Free cash flow
- −65.2%
- Total debt
- +4.06%
Quarter to September 2026, against a year earlier
126.56
0.19
−0.15%
Follow ITGR
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
42.11 | 25.33 | 21.67 | 26.86 |
+8 more quarters Free account |
P/S ratio |
2.36 | 1.72 | 1.63 | 1.47 | |
P/FCF ratio |
53.20 | 28.64 | 30.52 | 26.17 | |
P/Operating CF |
117.37 | 53.21 | 122.15 | 49.16 | |
P/B ratio |
2.49 | 1.85 | 1.78 | 1.56 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
3.04 | 2.41 | 2.32 | 2.12 | |
EV/EBITDA |
18.73 | 13.75 | 12.46 | 10.93 | |
EV/Operating CF |
31.47 | 21.64 | 22.75 | 19.99 | |
EV/FCF |
68.72 | 40.06 | 43.63 | 37.66 | |
Quick Ratio |
1.79 | 1.66 | 1.63 | 1.57 | |
Current Ratio |
3.98 | 3.73 | 3.75 | 3.32 | |
Net Debt/EBITDA |
19.54 | 17.93 | 18.92 | 12.85 | |
Debt/Assets |
37.39% | 37.66% | 38.22% | 35.59% | |
Debt/Equity |
0.74 | 0.75 | 0.77 | 0.69 | |
Asset Turnover |
0.54 | 0.54 | 0.55 | 0.57 | |
Operating CF/Net income |
2.45 | 2.53 | 1.50 | 1.14 | |
Capex/Depreciation |
(0.57) | (0.63) | (0.65) | (0.74) | |
Interest Coverage |
2.91 | 3.41 | 3.27 | 6.03 | |
Research and Development Expense of Revenue |
3.01% | 2.43% | 3.70% | 2.14% | |
Selling, General and Administrative Expense of Revenue |
12.04% | 12.43% | 13.36% | 12.12% | |
Intangible Assets out of Total Assets |
0.55 | 0.55 | 0.56 | 0.57 | |
Share Based Compensation of Revenue |
1.16% | 1.16% | 1.52% | 1.22% | |
Graham Net Nets |
(0.20) | (0.28) | (0.31) | (0.33) | |
Graham Number |
58.52 | 64.78 | 67.25 | 57.48 | |
Earnings Yield |
2.37% | 3.95% | 4.61% | 3.72% | |
Free Cash Flow Yield |
1.88% | 3.49% | 3.28% | 3.82% | |
Revenue per Share |
13.21 | 13.65 | 12.82 | 13.59 | |
Operating CF per Share |
1.08 | 1.76 | 0.72 | 1.60 | |
Capex per Share |
(0.60) | (0.67) | (0.70) | (0.79) | |
Free Cash Flow per Share |
0.47 | 1.09 | 0.02 | 0.80 | |
Cash per Share |
0.42 | 0.63 | 0.24 | 0.49 | |
Shareholders Equity per Share |
50.74 | 50.54 | 49.50 | 50.28 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
50.74 | 50.54 | 49.50 | 50.28 | |
Free Cash Flow |
16.10 | 36.99 | 0.79 | 27.94 | |
Working Capital |
600.27 | 593.49 | 568.42 | 538.06 | |
Capital Expenditures |
(20.53) | (22.75) | (23.90) | (27.48) | |
Net Current Asset Value |
(866.15) | (894.21) | (940.06) | (893.84) | |
EV/EBIT |
36.89 | 24.87 | 21.18 | 17.72 | |
Capex to Sales |
0.05 | 0.05 | 0.05 | 0.06 | |
Price to Operating Income |
28.56 | 17.78 | 14.82 | 12.31 | |
| Other line items | |||||
Average Receivables |
327.62 | 320.50 | 302.01 | 295.67 | |
Average Payables |
110.87 | 114.61 | 113.51 | 107.31 | |
Average Inventory |
271.06 | 277.25 | 272.29 | 250.43 | |
Average Assets |
3,395.62 | 3,397.27 | 3,354.71 | 3,244.27 | |
Average Common Equity |
1,736.12 | 1,711.14 | 1,651.80 | 1,682.93 |
Columns are period end dates · fundamentals updated 2 Nov 2026